Nervgen Pharma NGEN
NASDAQ NGEN
$1.42 -0.08 (-5.33%)
At close: Oct 22, 2026 · 4:00 PM EDT

Nervgen Pharma (NGEN) Assets (2024 - 2026)

Updated

Nervgen Pharma (NGEN) posted Assets of $65.2 million for the quarter ended Jun 30, 2026, up 330.6% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Assets (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma's Assets came in at $16.61 million, up 16.7% from the prior year.

  • In prior years, Nervgen Pharma's Assets was $14.23 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 197.43 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 135.12 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 201.13 Bn
10 Nervgen Pharma 103.43 Mn 2.31 Mn - 63.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 63.47 Mn
Mar 31, 2026 14.91 Mn
Dec 31, 2025 16.95 Mn
Dec 31, 2024 13.58 Mn
API Access

Nervgen Pharma Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=NGEN&period=max&api_key=YOUR_API_KEY